Sg Americas Securities, LLC I Bio, Inc. Transaction History

Sg Americas Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$0.23 - $0.46 $6,384 - $12,768	-27,758 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$0.3 - $0.61 $8,530 - $17,344	-28,434 Reduced 50.6%	27,758 $12,000
Q4 2021 Feb 07, 2022	SELL	$0.55 - $1.04 $43,632 - $82,504	-79,331 Reduced 58.54%	56,192 $31,000
Q3 2021 Nov 01, 2021	BUY	$1.06 - $1.52 $143,654 - $205,994	135,523 New	135,523 $144,000
Q2 2021 Aug 12, 2021	SELL	$1.22 - $1.65 $59,063 - $79,881	-48,413 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.18 - $2.62 $41,556 - $92,268	35,217 Added 266.88%	48,413 $75,000
Q4 2020 Feb 04, 2021	BUY	$1.05 - $2.24 $13,855 - $29,559	13,196 New	13,196 $14,000
Q3 2020 Nov 09, 2020	SELL	$1.7 - $6.41 $44,041 - $166,063	-25,907 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$0.87 - $2.46 $22,539 - $63,731	25,907 New	25,907 $58,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.7M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.